Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)
- PMID: 19995753
- DOI: 10.1136/ard.2009.119396
Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)
Abstract
The Fos and Jun proteins are members of the AP-1 transcription factor complex, which is a central regulator for many cellular functions. This paper summarises the important functions of Fos proteins in bone development, with special emphasis on the Fos-related proteins Fra-1 and Fra-2. These factors determine the functions of osteoblasts and osteoclasts and regulate cytokine signalling during bone development. Likewise, the Jun proteins control the expression of cytokines and chemokines and are probably causally involved in inflammatory skin diseases such as psoriasis. Investigations into the molecular mechanisms responsible for skin inflammation have revealed that Jun proteins control cytokine expression, such as granulocyte colony-stimulating factor, IL-6 and tumour necrosis factor alpha by transcriptional and posttranscriptional pathways. Finally, the paper discusses the relevance of the Jun-dependent mouse model for psoriasis for preclinical studies in the field of anti-angiogenic therapies.
Similar articles
-
Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation.Endocrinology. 1996 Oct;137(10):4398-408. doi: 10.1210/endo.137.10.8828501. Endocrinology. 1996. PMID: 8828501
-
Functions of AP1 (Fos/Jun) in bone development.Ann Rheum Dis. 2002 Nov;61 Suppl 2(Suppl 2):ii40-2. doi: 10.1136/ard.61.suppl_2.ii40. Ann Rheum Dis. 2002. PMID: 12379619 Free PMC article. Review.
-
Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.Mol Cell Biochem. 2013 Aug;380(1-2):143-51. doi: 10.1007/s11010-013-1667-x. Epub 2013 Apr 28. Mol Cell Biochem. 2013. PMID: 23625206
-
Signalling in inflammatory skin disease by AP-1 (Fos/Jun).Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 92):S44-9. Epub 2015 Oct 12. Clin Exp Rheumatol. 2015. PMID: 26458100 Review.
-
Transcriptional coactivators potentiating AP-1 function in bone.Front Biosci. 1998 Aug 1;3:d838-48. doi: 10.2741/a327. Front Biosci. 1998. PMID: 9682038 Review.
Cited by
-
Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice.J Biol Chem. 2012 Dec 7;287(50):41903-13. doi: 10.1074/jbc.M112.415182. Epub 2012 Oct 16. J Biol Chem. 2012. PMID: 23076146 Free PMC article.
-
Inhibition of c-Fos expression attenuates IgE-mediated mast cell activation and allergic inflammation by counteracting an inhibitory AP1/Egr1/IL-4 axis.J Transl Med. 2021 Jun 15;19(1):261. doi: 10.1186/s12967-021-02932-0. J Transl Med. 2021. PMID: 34130714 Free PMC article.
-
MiR-142-3p is a RANKL-dependent inducer of cell death in osteoclasts.Sci Rep. 2016 Apr 26;6:24980. doi: 10.1038/srep24980. Sci Rep. 2016. PMID: 27113904 Free PMC article.
-
Sarsasapogenin Suppresses RANKL-Induced Osteoclastogenesis in vitro and Prevents Lipopolysaccharide-Induced Bone Loss in vivo.Drug Des Devel Ther. 2020 Aug 24;14:3435-3447. doi: 10.2147/DDDT.S256867. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 32943842 Free PMC article.
-
Heat-Killed Latilactobacillus sakei CNSC001WB and Lactobacillus pentosus WB693 Have an Anti-inflammatory Effect on LPS-Stimulated RAW 264.7 Cells.Probiotics Antimicrob Proteins. 2024 Oct;16(5):1875-1885. doi: 10.1007/s12602-023-10139-6. Epub 2023 Aug 17. Probiotics Antimicrob Proteins. 2024. PMID: 37589784
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous